Propericiazine in psychiatric emergencies. A controlled comparative study.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000374:Aggression / Q000187:drug effects; D002746:Chlorpromazine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004644:Emotions / Q000187:drug effects; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D009497:Neurotic Disorders / Q000188:drug therapy; D009570:Nitriles / Q000627:therapeutic use*; D010640:Phenothiazines / Q000009:adverse effects / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000188:drug therapy; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D009570:Nitriles; D010640:Phenothiazines; D010880:Piperidines; D014149:Tranquilizing Agents; D002746:Chlorpromazine